|
National Acquisition Center - Federal Supply Schedule Service - Pharmaceuticals
 |
M5-Q50A-03-R2 (Drugs, Pharmaceuticals & Hematology Related Products) refreshed solicitation released April 1, 2008 designed in a new format.  |
| M5-Q52A-04-R2 (InVitro Diagnostics, Reagants, Test Kits & Sets) anticipated release date 2009 designed in a new format. |
 |
|
 |
Help Desk - For general questions about schedule solicitations, quarterly sales reports, subcontracting plans and Freedom of Information Act (FOIA)
(708) 786-7737 - Phone
(708) 786-5828 - Fax
helpdesk.ammhinfss@va.gov |
Team Phone Directory - Reflects contract administrator for current FSS contracts (64kb)  |
| Report a broken link |
| Make a suggestion |
 |
FSS » Pharmaceuticals
The Department of Veteran Affairs Federal Supply Schedules Pharmaceuticals team is responsible for negotiating, awarding, administering and maintaining contracts for Drugs, Pharmaceuticals, InVitro Diagnostics, Reagents, and Test Kits & Sets.
FSC 65, Part I, Section B: Drugs, Pharmaceuticals & Hematology Related Products
- 65IB Information Page - Access detailed information about the 65IB drugs, pharmaceuticals & hematology related products schedule
- 42-2A Public Law Information Page - Access detailed information about products classified under special item number (SIN) 42-2A covered drugs
- 65IB Solicitation M5-Q50A-03-R2 - Download the latest solicitation and associated attachments

- FSC 65, Part VII: InVitro Diagnostics, Reagents, Test Kits & Sets
65VII Information Page (Coming soon)
- 65VII Solicitation - Download the latest solicitation and associated attachments

To access contract administrative forms (e.g. Request for Modification) please go to the respective schedule page listed below:
- 65IB - Drugs, Pharmaceuticals & Hematology Related Products All SINs except 42-2A
- 65IB 42-2A - Products classified under SIN 42-2A and regulated by PL 102-585
- 65VII - InVitro Diagnostics, Reagents, Test Kits & Sets (Coming soon)
- Signatory Authority Form (77kb)

Return to top 
Return to top 
Return to top 
Return to top 
|